Premium
EXTRANODAL DISEASE IS ASSOCIATED WITH SHORTER PROGRESSION‐FREE SURVIVAL AFTER CD19‐CAR T‐CELL THERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Author(s) -
Bücklein V.,
Blumenberg V.,
Ackermann J.,
Frölich L.,
Winkelmann M.,
Schmidt C.,
Rejeski K.,
Ruzicka M.,
Müller N.,
von Baumgarten L.,
Schöberl F.,
Hildebrandt M.,
Humpe A.,
Kunz W.,
Hoster E.,
von Bergwelt M.,
Subklewe M.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.183_2880
Subject(s) - medicine , diffuse large b cell lymphoma , refractory (planetary science) , lymphoma , gastroenterology , oncology , surgery , astrobiology , physics